MAIA Biotechnology
MAIA
MAIA
20 hedge funds and large institutions have $2.26M invested in MAIA Biotechnology in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
–
Holders Change %
0%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$104K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$66.5K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$25.9K |
| 4 |
NW
Naviter Wealth
Little Rock,
Arkansas
|
+$16.2K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$10.7K |
Top Sellers
| 1 |
Jane Street
New York
|
-$77.3K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$14.8K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$6K |
| 4 |
HFF
Halter Ferguson Financial
Carmel,
Indiana
|
-$5.3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.67K |
